Brain Infection Reports Prompt Boxed Warning On Adcetris
By Bibeka Shrestha ( January 13, 2012, 3:34 PM EST) -- Federal regulators said Friday they had slapped a boxed warning on Adcetris — a lymphoma drug developed by Seattle Genetics Inc. and a Takeda Pharmaceutical Co. Ltd. subsidiary — after receiving reports of a rare and potentially deadly brain infection in Adcetris users....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.